Candida albicans
- Generic Name
- Candida albicans
- Brand Names
- Candin
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- 4D7G21HDBC
- Background
Candida albicans is a fungus which can provoke allergic reactions. Candida albicans is used in allergenic testing.
- Associated Conditions
- -
- Associated Therapies
- -
A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 4
- First Posted Date
- 2022-08-31
- Last Posted Date
- 2022-11-23
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 20
- Registration Number
- NCT05522517
- Locations
- 🇧🇪
Clinical Pharmacology Unit, Antwerpen, Belgium
Assessment of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 Peptide Antigens
- First Posted Date
- 2022-01-31
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- Tonix Pharmaceuticals, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT05216510
- Locations
- 🇺🇸
Clinical Site, Berlin, New Jersey, United States
A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 2
- First Posted Date
- 2020-11-02
- Last Posted Date
- 2021-06-21
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 13
- Registration Number
- NCT04611971
- Locations
- 🇧🇪
Clinical Pharmacology Unit, Merksem, Belgium
A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 1
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2021-06-21
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 12
- Registration Number
- NCT04589026
- Locations
- 🇧🇪
Clinical Pharmacology Unit, Merksem, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath